Phytoactive Molecules and Nanodelivery Approaches for Breast Cancer Treatment: Current and Future Perspectives
- 1 March 2025
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 26 (6) , 795-812
Abstract
One of the most common malignancies in women, breast cancer accounts for nearly 25% of all cancer cases. Breast cancer is a diverse cancer form that exhibits variability in both morphology and molecular characteristics and is linked to numerous risk factors. Although various approaches and research are ongoing in the treatment and prevention of breast cancer, medication resistance in the current breast cancer treatment contributes to the disease's relapse and recurrence. Phytoactive molecules are the subject of growing research in both breast cancer prevention and treatment, but currently used conventional medicines and techniques limit their application. In recent years, significant advancements have been made in the field of nanotechnology, which has proven to be essential in the fight against drug resistance. The transport of synthetic and natural anticancer molecules via nanocarriers has recently been added to breast cancer therapy, greatly alleviating the constraints of the current approach. In light of these developments, interest in nano-delivery studies of phytoactive molecules has also increased. In this review, research of phytoactive molecules for breast cancers along with their clinical studies and nanoformulations, was presented from current and future perspectives.Keywords
This publication has 189 references indexed in Scilit:
- α‐Mangostin induces oxidative damage, mitochondrial dysfunction, and apoptosis in a triple‐negative breast cancer modelPhytotherapy Research, 2023
- Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of actionCellular and Molecular Life Sciences, 2022
- Resveratrol reverses TGF‐β1‐mediated invasion and metastasis of breast cancer cells via the SIRT3/AMPK/autophagy signal axisPhytotherapy Research, 2022
- Breast cancer: an up‐to‐date review and future perspectivesCancer Communications, 2022
- Apigenin alleviates resistance to doxorubicin in breast cancer cells by acting on the JAK/STAT signaling pathwayMolecular Biology Reports, 2022
- Potential of green-synthesized selenium nanoparticles using apigenin in human breast cancer MCF-7 cellsEnvironmental Science and Pollution Research, 2022
- Breast Cancer TreatmentJAMA, 2019
- Dual drug-loaded paclitaxel–thymoquinone nanoparticles for effective breast cancer therapyJournal of Nanoparticle Research, 2015
- Soy isoflavone genistein induces cell death in breast cancer cells through mobilization of endogenous copper ions and generation of reactive oxygen speciesMolecular Nutrition & Food Research, 2010
- PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in RatPharmaceutical Research, 2009